EGFR-HER2 inhibitor Canertinib dihydrochloride, Purity ≥98%

Cat. No.: X23-10-ZQ1058

EGFR-HER2 inhibitor Canertinib dihydrochloride, Purity ≥98%

Synonym: Canertinib dihydrochloride; 289499-45-2; Canertinib HCl; Canertinib (dihydrochloride); CI-1033; Canertinib 2HCl; EGFR-HER2 inhibitor

  • MDL: MFCD09954112
  • CAS Number: 289499-45-2
  • Compound CID: 156413
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Canertinib dihydrochloride, soluble in DMSO and water and insoluble in ethanol, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and ErbB2.
Molecular Weight
558.86
Molecular Formula
C24H27Cl3FN5O3
Targets
EGFR: 7.4 nM; ErbB2: 9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 88 mg/mL (157.46 mM); Water: 18 mg/mL (32.2 mM); Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Canertinib dihydrochloride can be used to irreversibly inhibit EGFR family members for oncology research.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0